321 related articles for article (PubMed ID: 27898412)
1. The Rise and Rise of Exome Sequencing.
Ku CS; Cooper DN; Patrinos GP
Public Health Genomics; 2016; 19(6):315-324. PubMed ID: 27898412
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
4. An automatic and efficient pipeline for disease gene identification through utilizing family-based sequencing data.
Song D; Li N; Liao L
Biomed Mater Eng; 2015; 26 Suppl 1():S1797-803. PubMed ID: 26405949
[TBL] [Abstract][Full Text] [Related]
5. Exome versus transcriptome sequencing in identifying coding region variants.
Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
[TBL] [Abstract][Full Text] [Related]
6. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing: dual role as a discovery and diagnostic tool.
Ku CS; Cooper DN; Polychronakos C; Naidoo N; Wu M; Soong R
Ann Neurol; 2012 Jan; 71(1):5-14. PubMed ID: 22275248
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
Krøigård AB; Thomassen M; Lænkholm AV; Kruse TA; Larsen MJ
PLoS One; 2016; 11(3):e0151664. PubMed ID: 27002637
[TBL] [Abstract][Full Text] [Related]
9. Combination of RNA- and exome sequencing: Increasing specificity for identification of somatic point mutations and indels in acute leukaemia.
Hansen MC; Herborg LL; Hansen M; Roug AS; Hokland P
Leuk Res; 2016 Dec; 51():27-31. PubMed ID: 27821287
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
[TBL] [Abstract][Full Text] [Related]
11. [The application of exome sequencing in human disease].
Rao S; Du T; Xu Q
Yi Chuan; 2014 Nov; 36(11):1077-86. PubMed ID: 25567866
[TBL] [Abstract][Full Text] [Related]
12. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
13. Revisiting Mendelian disorders through exome sequencing.
Ku CS; Naidoo N; Pawitan Y
Hum Genet; 2011 Apr; 129(4):351-70. PubMed ID: 21331778
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of next-generation sequencing for Mendelian diseases.
Jamuar SS; Tan EC
Hum Genomics; 2015 Jun; 9(1):10. PubMed ID: 26076878
[TBL] [Abstract][Full Text] [Related]
15. Exome and whole-genome sequencing for gene discovery: the future is now!
Majewski J; Rosenblatt DS
Hum Mutat; 2012 Apr; 33(4):591-2. PubMed ID: 22411407
[No Abstract] [Full Text] [Related]
16. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
McInerney-Leo AM; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing greatly expedites the progressive research of Mendelian diseases.
Zhang X
Front Med; 2014 Mar; 8(1):42-57. PubMed ID: 24384736
[TBL] [Abstract][Full Text] [Related]
18. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease.
Ku CS; Tan EK; Cooper DN
J Med Genet; 2013 Apr; 50(4):203-11. PubMed ID: 23396985
[TBL] [Abstract][Full Text] [Related]
19. Discovery of mutations for Mendelian disorders.
Alkuraya FS
Hum Genet; 2016 Jun; 135(6):615-23. PubMed ID: 27068822
[TBL] [Abstract][Full Text] [Related]
20. Statistical guidance for experimental design and data analysis of mutation detection in rare monogenic mendelian diseases by exome sequencing.
Zhi D; Chen R
PLoS One; 2012; 7(2):e31358. PubMed ID: 22348076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
